If you liked this article you might like

Freeport-McMoRan, Apple Hospitality REIT, Abbott Laboratories: 'Mad Money' Lightning Round
Reversal of Fortunes: Cramer's 'Mad Money' Recap (Thursday 7/27/17)
Novartis Passes FDA Blood Cancer Panel 'With Flying Colors,' Gives Positive Read Through For Others
Landmark Novartis Immunotherapy Faces Crucial FDA Hearing Wednesday